Patient Guide: A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma.

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 261 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04680052
Status: ACTIVE_NOT_RECRUITING
Condition: Lymphoma, Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone
Phase: PHASE3

Find a Study Location Near You

This study is available at 261 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Concord, California
  • Greenbrae, California
  • Pasadena, California
  • • And 258 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily